XOMA Royalty (XOMA) Gains from Investment Securities (2014 - 2016)
XOMA Royalty (XOMA) reported Gains from Investment Securities of -$9000.0 for Q4 2016, down 100.14% on a YoY basis from $6.4 million in Q1 2016, and up 96.54% sequentially from -$260000.0 in Q3 2016.
XOMA Royalty (XOMA) Gains from Investment Securities (2014 - 2016) Analysis & Trends
XOMA Royalty (XOMA) has 3 years of Gains from Investment Securities data on file, last reported at -$9000.0 in Q4 2016.
- For the quarter ending Q4 2016, Gains from Investment Securities fell 100.14% year-over-year to -$9000.0; the trailing twelve-month figure through Dec 2016 stood at -$10.5 million (up 41.25% YoY), and the FY2016 full-year result was -$10.5 million, up 41.25% from the prior year.
- Gains from Investment Securities improved to -$9000.0 in Q4 2016, from -$260000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $6.4 million in Q4 2015 to a low of -$24.4 million in Q3 2015.
- A 3-year average of -$4.6 million and a median of -$1.8 million in 2016 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities jumped 152.9% in 2015 and plunged 17430.0% in 2016, its largest moves.
- Tracing XOMA's Gains from Investment Securities over 3 years: stood at -$12.1 million in 2014, then jumped by 152.9% to $6.4 million in 2015, then tumbled by 100.14% to -$9000.0 in 2016.
- Business Quant data shows XOMA's Gains from Investment Securities at -$9000.0 in Q4 2016, -$260000.0 in Q3 2016, and -$3.3 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -9,000.00 |
| Dec 31, 2016 | -9,000.00 |
| Sep 30, 2016 | -260,000.00 |
| Sep 30, 2016 | -260,000.00 |
| Jun 30, 2016 | -3.26 Mn |
| Jun 30, 2016 | -3.26 Mn |
| Mar 31, 2016 | -6.93 Mn |
| Mar 31, 2016 | -6.93 Mn |
| Dec 31, 2015 | 6.39 Mn |
| Dec 31, 2015 | 6.39 Mn |
| Sep 30, 2015 | -24.42 Mn |
| Sep 30, 2015 | -24.42 Mn |
| Jun 30, 2015 | 176,000.00 |
| Jun 30, 2015 | 176,000.00 |
| Mar 31, 2015 | 40,000.00 |
| Mar 31, 2015 | 40,000.00 |
| Dec 31, 2014 | -12.09 Mn |
| Dec 31, 2014 | -12.09 Mn |
| Sep 30, 2014 | -5.72 Mn |
| Sep 30, 2014 | -5.72 Mn |